Seneffe, March 25, 2013. Eckert & Ziegler BEBIG s.a. (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) and Core Oncology, Inc. signed an out of court settlement today resolving their legal dispute over the repayment of a loan. In the settlement, Core Oncology agrees to pay USD 1.7 million to Eckert & Ziegler BEBIG s.a. to settle all claims. This payment will result in "other income" in the first quarter of 2013.

In November 2009, both companies entered into a strategic alliance agreement, in which, among other things, Eckert & Ziegler BEBIG received an option to take over Core Oncology and made a short-term loan to that company. Since Core Oncology was not taken over and the loan was not repaid in accordance with the original agreement an, Eckert & Ziegler BEBIG filed a complaint with the U.S. Federal Court in Seattle in early 2011 seeking to rescind the contracts.

"With this out of court settlement, we have avoided many years of litigation, and our financial power has also been strengthened. No further legal costs will be incurred," said Dr. Edgar Löffler, Managing Director of Eckert & Ziegler BEBIG.

Your contact person for questions:
Eckert & Ziegler BEBIG s.a.
Karolin Riehle, Investor Relations
Tel.: +32 (0) 64 520 808, ir@bebig.eu:
mailto:ir@bebig.eu, www.bebig.eu:
http://www.bebig.eu/




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE

HUG#1688068

© GlobeNewswire - 2013